1. Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
- Author
-
Manuel López-López, Pablo Huertas, María Luisa Moyá, Eva Bernal, Clara B. García-Calderón, José Antonio Lebrón, Iván V. Rosado, Pilar López-Cornejo, Francisco José Ostos, Fernando R. Balestra, Vitaly I. Kalchenko, Roman V. Rodik, [Lebrón,JA, Bernal,E, Moyá,ML, López-Cornejo,P, Ostos,FJ] Department of Physical Chemistry, Faculty of Chemistry, University of Seville, Seville, Spain. [López-López,M] Department of Chemical Engineering, Physical Chemistry and Materials Science, Faculty of Experimental Sciences, University of Huelva, Huelva, Spain. [García-Calderón,CB, V. Rosado,I] Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain. [Balestra,FR, Huertas,P] Department of Genetics, Faculty of Biology, University of Seville, Seville, Spain. [Balestra,FR, Huertas,P] Andalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), University of Seville-CSIC-University Pablo de Olavide, Seville, Spain. [Rodik,RV, Kalchenko,VI] Institute of Organic Chemistry, National Academy of Science of Ukraine, Kiev, Ukraine., This work was financed by the Consejería de Conocimiento, Innovación y Universidades de la Junta de Andalucía (FQM-206, FQM-274, and PY20-01234), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), RTI2018-100692-B-100, P18-RT-1271, PI18-0005-2018, VI-PP AY.SUPLEM 2019, RYC-2015-18670, The R+D+I grant PID2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de investigación/10.13039/501100011033 (P.H.) and the European Union (Feder Funds). The authors thank the University of Seville for the grant VPPI-US. J.A.L. also thanks the Fundación ONCE funded by the Fondo Social Europeo., Junta de Andalucía, Universidad de Sevilla, Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Economía y Competitividad (España), European Commission, Fundación ONCE, Universidad de Sevilla. Departamento de Química Física, and Universidad de Sevilla. Departamento de Genética
- Subjects
liposomes ,Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicin [Medical Subject Headings] ,Chemicals and Drugs::Pharmaceutical Preparations::Dosage Forms::Delayed-Action Preparations [Medical Subject Headings] ,Doxorrubicina ,Phospholipid ,Pharmaceutical Science ,Technology and Food and Beverages::Technology, Industry, and Agriculture::Manufactured Materials::Nanostructures [Medical Subject Headings] ,doxorubicin ,Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids [Medical Subject Headings] ,Article ,chemistry.chemical_compound ,Pharmacy and materia medica ,Anatomy::Cells::Cells, Cultured::Cell Line [Medical Subject Headings] ,Amphiphile ,Calixarene ,23 Química ,Lipid bilayer ,transfection efficiency ,cationic calix[4]arenes ,Liposome ,Chemistry ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings] ,technology, industry, and agriculture ,Transfection efficiency ,Combinatorial chemistry ,Controlled release ,Cationic calix[4]arenes ,RS1-441 ,Nucleic acids ,Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Calixarenes [Medical Subject Headings] ,nucleic acids ,Liposomas ,Encapsulación celular ,Doxorubicin ,Drug delivery ,Liposomes ,encapsulation ,Ácidos nucleicos ,lipids (amino acids, peptides, and proteins) ,Encapsulation ,Nanocarriers ,Chemicals and Drugs::Biomedical and Dental Materials::Membranes, Artificial::Liposomes [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Transfer Techniques::Transfection [Medical Subject Headings] - Abstract
The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC12)4, were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC12)4/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC12)4/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug., This work was financed by the Consejería de Conocimiento, Innovación y Universidades de la Junta de Andalucía (FQM-206, FQM-274, and PY20-01234), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), RTI2018-100692-B-100; P18-RT-1271; PI18-0005-2018; VI-PP AY.SUPLEM- 2019; RYC-2015-18670, The R+D+I grant PID2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/501100011033 (P.H.) and the European Union (Feder Funds). The authors thank the University of Seville for the grant VPPI-US. J.A.L. also thanks the Fundación ONCE funded by the Fondo Social Europeo.
- Published
- 2021